REVIEW
|
doi:10.20944/preprints202308.0190.v2
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
Savolitinib; MET-TKI; NSCLC; gastric cancer; renal cell carcinoma; pancreatic cancer
Online: 7 August 2023 (10:03:49 CEST)